Efficacy and safety of R-GemOx regimen for relapsed refractory B-cell lymphoma: a single-arm Meta analysis

Objective Systematic evaluation of the efficacy and safety of the Rituximab plus gemcitabine and oxaliplatin(R-GemOx) regimen for the treatment of relapsed refractory B-cell lymphoma.Methods The PubMed, Embase, CNKI, CBM, VIP and Wan-Fang databases were systematically searched for experimental and o...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Guo-Xin HUANG, Qi-Long CAO, Jian-Zhou TIAN, Jin-Wei AI, Gao-Jing QU, Bin PEI
Aineistotyyppi:	Artigo
Kieli:	Chinês
Julkaistu:	Editorial Office of New Medicine 2023-12-01
Sarja:	Yixue xinzhi zazhi
Aiheet:	r-gemox relapsed refractory b-cell lymphoma single-arm meta analysis efficacy safety
Linkit:	https://yxxz.whuznhmedj.com/futureApi/storage/attach/2312/HgPZTGgin6Uxjn1YHPsvEIjsWtvWFtjTViw1YMFG.pdf
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!